Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer

INTRODUCTION: Triple negative breast cancer (TNBC) is the most aggressive and hard-to-treat subtype of breast cancer, affecting 10-20% of all women diagnosed with breast cancer. Surgery, chemotherapy and hormone/Her2 targeted therapies are the cornerstones of treatment for breast cancer, but women w...

Descripción completa

Detalles Bibliográficos
Autores principales: Niavarani, Seyedeh-Raheleh, St-Cyr, Guillaume, Daniel, Lauren, Lawson, Christine, Giguère, Hugo, Alkayyal, Almohanad A., Tai, Lee-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968850/
https://www.ncbi.nlm.nih.gov/pubmed/36860852
http://dx.doi.org/10.3389/fimmu.2023.1098344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968850/
https://www.ncbi.nlm.nih.gov/pubmed/36860852
http://dx.doi.org/10.3389/fimmu.2023.1098344

Ejemplares similares